Profile: Biocryst Pharmaceuticals Inc. designs and develops novel small-molecule pharmaceuticals that block key enzymes involved in cancer, cardiovascular & autoimmune diseases. Our advanced drug candidate, forodesine HCl, is an investigational purine nucleoside phosphorylase (PNP) inhibitor for the treatment of T-cell mediated disorders.